Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Whitehawk Therapeutics Logo
Whitehawk Therapeutics Growth Score
66
CB Rank
1992
Heat Score
71
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Founded
obfuscation
PublicPost-IPO Equity Pacific Palisades, California, United States11-50 www.whitehawktx.com
Biopharma
Biotechnology
Life Science
Oncology
Overview

Whitehawk Therapeutics
Total Funding
obfuscation
Growth Score
66
Heat Score
71

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score66
9 pts
in past quarter
Heat Score 71
54 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Whitehawk Therapeutics

CB Rank
1992
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Founded
obfuscation
PublicPost-IPO Equity Pacific Palisades, California, United States11-50 www.whitehawktx.com
Biopharma
Biotechnology
Life Science
Oncology

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Whitehawk Therapeutics, Inc.
Also Known As Aadi Bioscience
Operating Status Active
Stock Symbol  NASDAQ:AADI
Company Type For Profit
Founders  Neil Desai
About the Company
Whitehawk medicines is a clinical-stage oncology medicines firm that combines modern technologies with recognized tumor biology to efficiently offer improved cancer treatments.
Phone Number (424) 744-8055
Contact Email info@aadibio.com
Predictions & Insights

Growth Insight

See this Growth Insight
Whitehawk Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

FYARRO™ (nab-sirolimus)
An mTOR inhibitor formulated as sirolimus albumin-bound nanoparticles for injectable suspension, used to treat cancers with mTOR pathway gene alterations, including advanced malignant PEComa.

Research & Development

Whitehawk Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Whitehawk Therapeutics Logo
Post-IPO Equity - Whitehawk Therapeutics
8
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Board Members and Advisors 7 Contacts 61

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,407
125.84%
 in past month

IT Spend

$1.9MThis year, Whitehawk Therapeutics is projected to spend $1.9M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Employee Discounts Logo
Employee Discounts
96
Incredibuild Logo
Incredibuild
94
Row-Based Cooling Logo
Row-Based Cooling
93

Active Website Tech Count

12Whitehawk Therapeutics is actively using 12 technologies for its website, according to BuiltWith. These include IPv6, CommonCrawl Top 5m, and  Japanese Yen.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
FYARRO Logo
FYARROSubsidiary
Frequently Asked Questions

Where is Whitehawk Therapeutics's headquarters? Whitehawk Therapeutics is located in Pacific Palisades, California, United States.Who invested in Whitehawk Therapeutics? Whitehawk Therapeutics has 28 investors including Avoro Capital Advisors and  Acuta Capital Partners.When was the last funding round for Whitehawk Therapeutics? Whitehawk Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Whitehawk Therapeutics's competitors? Alternatives and possible competitors to Whitehawk Therapeutics may include Tango Therapeutics, Nuvalent, and  Avenzo Therapeutics.How much funding has Whitehawk Therapeutics raised to date? Whitehawk Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|